AI-generated summary
The authors studied fluorescent light energy, a photobiomodulation therapy, as an add-on treatment in eight client-owned dogs with cutaneous epitheliotropic lymphoma, using one treated lesion and one untreated control lesion per dog. They report no statistically significant differences between sites, though some favourable trends and owner-rated responses were noted, and conclude the therapy appears safe.
- Participants
- 8
- Who or what was studied
- Eight client-owned dogs diagnosed with canine cutaneous epitheliotropic lymphoma by biopsy and immunohistochemistry
- Limits stated in the abstract
- The study had a very small sample of eight dogs, no statistically significant treatment effect was demonstrated, and one dog was withdrawn from the study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.